BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36864577)

  • 1. Relevance of glyco-biomakers and glycan profiles in cancer stem cells.
    Pujari R; Dubey SK
    Glycobiology; 2024 Apr; 34(6):. PubMed ID: 36864577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell marker glycosylation: Nature, function and significance.
    Mallard BW; Tiralongo J
    Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.
    Barkeer S; Chugh S; Batra SK; Ponnusamy MP
    Neoplasia; 2018 Aug; 20(8):813-825. PubMed ID: 30015157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant glycosylation as biomarker for cancer: focus on CD43.
    Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
    Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation: a hallmark of cancer?
    Vajaria BN; Patel PS
    Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glycoproteomic approach to identify novel glycomarkers for cancer stem cells.
    Sawanobori A; Moriwaki K; Takamatsu S; Kamada Y; Miyoshi E
    Proteomics; 2016 Dec; 16(24):3073-3080. PubMed ID: 26949200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
    Carvalho S; Reis CA; Pinho SS
    Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of functional glycans between cancer stem cells and normal stem cells.
    Sasaki N; Itakura Y; Gomi F; Hirano K; Toyoda M; Ishiwata T
    Histol Histopathol; 2019 Sep; 34(9):995-1007. PubMed ID: 31025698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the trail of the glycan codes stored in cancer-related cell adhesion proteins.
    Hoja-Łukowicz D; Przybyło M; Duda M; Pocheć E; Bubka M
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3237-3257. PubMed ID: 27565356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
    Pearson AJ; Gallagher ES
    Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
    Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
    BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
    Lange T; Samatov TR; Tonevitsky AG; Schumacher U
    Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer.
    Kang JG; Ko JH; Kim YS
    BMB Rep; 2011 Dec; 44(12):765-71. PubMed ID: 22189678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer glycan epitopes: biosynthesis, structure and function.
    Pearce OMT
    Glycobiology; 2018 Sep; 28(9):670-696. PubMed ID: 29546349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
    Haga Y; Ueda K
    Glycoconj J; 2022 Apr; 39(2):303-313. PubMed ID: 35156159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers of cancer stem cells in solid tumors.
    Xia P
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):102-11. PubMed ID: 24359139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.